Ritlecitinib in Patients With Keloids or Those Undergoing Keloidectomy
Clinical trial NCT06373458 · RECRUITING
Trial details
- NCT number
- NCT06373458
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-13
- Primary completion
- 2027-08-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.